... protect against postmeno-pausal loss of bone mass. Frequently,conjugated estrogens are used (p. 254 ).Because estrogen monotherapy increas-es the risk of uterine cancer, a gestagenneeds to be ... given concurrently (exceptafter hysterectomy), as e.g., in an oralcontraceptive preparation (p. 256 ).Under this therapy, menses will contin-ue. The risk of thromboembolic disor-ders is increased ... and gastric mucus membranes; tab-lets should be swallowed with a reason-able amount of water (250 mL) and thepatient should keep in an upright posi-tion for 30 min following drug intake.318...